"regorafenib" meaning in All languages combined

{
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "regorafenib (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Medicine",
          "orig": "en:Medicine",
          "parents": [
            "Biology",
            "Sciences",
            "All topics",
            "Fundamental"
          ],
          "source": "w"
        }
      ],
      "examples": [
        {
          "ref": "2015 July 4, Benoist Chibaudel et al., “STRATEGIC-1: A multiple-lines, randomized, open-label GERCOR phase III study in patients with unresectable wild-type RAS metastatic colorectal cancer”, in BMC Cancer, volume 15, →DOI",
          "text": "If tumor progression occurs during third-line therapy, patients are exposed to all standard therapeutic agents, except regorafenib.",
          "type": "quotation"
        }
      ],
      "glosses": [
        "A particular oral multi-kinase inhibitor"
      ],
      "id": "en-regorafenib-en-noun-sxor1Jmu",
      "links": [
        [
          "medicine",
          "medicine"
        ]
      ],
      "raw_glosses": [
        "(medicine) A particular oral multi-kinase inhibitor"
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "sciences"
      ],
      "wikipedia": [
        "regorafenib"
      ]
    }
  ],
  "word": "regorafenib"
}

{
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "regorafenib (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English entries with incorrect language header",
        "English lemmas",
        "English nouns",
        "English terms with quotations",
        "English uncountable nouns",
        "en:Medicine"
      ],
      "examples": [
        {
          "ref": "2015 July 4, Benoist Chibaudel et al., “STRATEGIC-1: A multiple-lines, randomized, open-label GERCOR phase III study in patients with unresectable wild-type RAS metastatic colorectal cancer”, in BMC Cancer, volume 15, →DOI",
          "text": "If tumor progression occurs during third-line therapy, patients are exposed to all standard therapeutic agents, except regorafenib.",
          "type": "quotation"
        }
      ],
      "glosses": [
        "A particular oral multi-kinase inhibitor"
      ],
      "links": [
        [
          "medicine",
          "medicine"
        ]
      ],
      "raw_glosses": [
        "(medicine) A particular oral multi-kinase inhibitor"
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "sciences"
      ],
      "wikipedia": [
        "regorafenib"
      ]
    }
  ],
  "word": "regorafenib"
}